IP Strategy Issues Statement on Arias Frontline K-Pop Release with RESCENE, Highlighting AI-Native Music Ownership on Story
GIG HARBOR, Wash., Feb. 17, 2026 (GLOBE NEWSWIRE) -- IP Strategy (Nasdaq:…
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscias Platform
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital…
Oculis Appoints Katie Kazem as Chief Legal Officer
Ms. Kazem brings extensive and global expertise in corporate governance and securities…
FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference
Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator…
Inventiva reports preliminary 2025 fiscal year financial results
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term…
TTEC Sets New Standard for AI-Driven Frontline Performance with TTEC Perform and TTEC RealSkill
AUSTIN, Texas, Feb. 16, 2026 (GLOBE NEWSWIRE) -- TTEC Holdings, Inc. (NASDAQ:…
UTI GROUP : Nominations et acquisition du groupe MALTEM par ROBINSON TECHNOLOGIES
A la suite de l’Assemblée Générale Extraordinaire qui s’est tenue le lundi…
Transactions in connection with share buyback programme
Company announcement No. 13/2026 16 February 2026 Transactions in connection with…
Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntingtons Disease and Establishes Clinical Advisory Board
HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled…
Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470
Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA…
